Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar(Brigham and Women's Hospital), Kornélia Polyák(Dana-Farber Cancer Institute), Ron Rowberry(Sutter Roseville Medical Center), Rong Fan(Yale Cancer Center), Helga Bergholtz(Oslo University Hospital), Lisa M. Coussens(Oregon Health & Science University), Anne Trinh(Brigham and Women's Hospital), Xiaoyuan Zi(Second Military Medical University), Joon Jeong(Yonsei University), Hege G. Russnes(Oslo University Hospital), Jon Wagner(Sutter Roseville Medical Center), Thérese Sørlie(Norwegian Cancer Society), Muhammad B. Ekram(Brigham and Women's Hospital), Elizabeth Min Hui Kim(Sutter Roseville Medical Center), Kirsten Babski(Sutter Roseville Medical Center), Deborah Dillon(Harvard University), Francisco Beça(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles H. McDonnell(Sutter Roseville Medical Center), Gordon J. Freeman(Dana-Farber Cancer Institute), Minsuk Kwak(Yale University), Franziska Michor(Dana-Farber Cancer Institute), Lin Liu(Institute of Natural Science), So Yeon Park(Seoul National University Bundang Hospital), Lina Ding(Brigham and Women's Hospital), Ying Su(Dana-Farber Cancer Institute), Sung Jin Huh(Harvard University Press), D. Craig Allred(The University of Texas Health Science Center at San Antonio), Kristie Bobolis(Sutter Roseville Medical Center), Andrea L. Richardson(Brigham and Women's Hospital), Judy E. Garber(Dana-Farber Cancer Institute)
Cited by 242
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
|Cancer Cell|2012|4.7k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k